CONTI, Pio
 Distribuzione geografica
Continente #
NA - Nord America 11.384
EU - Europa 6.230
AS - Asia 6.158
SA - Sud America 659
Continente sconosciuto - Info sul continente non disponibili 549
AF - Africa 100
OC - Oceania 7
Totale 25.087
Nazione #
US - Stati Uniti d'America 11.002
SG - Singapore 2.310
CN - Cina 1.768
UA - Ucraina 1.055
IE - Irlanda 834
GB - Regno Unito 826
TR - Turchia 784
IT - Italia 748
SE - Svezia 697
RU - Federazione Russa 661
BR - Brasile 536
DE - Germania 490
VN - Vietnam 489
FR - Francia 470
IN - India 383
FI - Finlandia 224
CA - Canada 198
HK - Hong Kong 84
BD - Bangladesh 64
AR - Argentina 57
MX - Messico 50
PL - Polonia 45
IL - Israele 43
ES - Italia 37
JP - Giappone 37
KR - Corea 37
ZA - Sudafrica 34
BE - Belgio 31
CZ - Repubblica Ceca 31
HN - Honduras 25
IQ - Iraq 25
CR - Costa Rica 22
NL - Olanda 19
JM - Giamaica 18
TT - Trinidad e Tobago 18
CO - Colombia 17
IR - Iran 17
EC - Ecuador 16
SC - Seychelles 15
EU - Europa 14
ID - Indonesia 14
CL - Cile 12
PH - Filippine 12
UZ - Uzbekistan 12
KE - Kenya 11
LT - Lituania 11
PK - Pakistan 11
SA - Arabia Saudita 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 9
RO - Romania 9
GT - Guatemala 8
MY - Malesia 8
PR - Porto Rico 8
TN - Tunisia 8
AT - Austria 7
EG - Egitto 7
NI - Nicaragua 7
SV - El Salvador 7
EE - Estonia 6
GP - Guadalupe 6
AU - Australia 5
DZ - Algeria 5
AZ - Azerbaigian 4
BB - Barbados 4
BG - Bulgaria 4
CW - ???statistics.table.value.countryCode.CW??? 4
DO - Repubblica Dominicana 4
GR - Grecia 4
JO - Giordania 4
MA - Marocco 4
MD - Moldavia 4
OM - Oman 4
AM - Armenia 3
ET - Etiopia 3
HR - Croazia 3
KZ - Kazakistan 3
ML - Mali 3
TH - Thailandia 3
UY - Uruguay 3
BM - Bermuda 2
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GY - Guiana 2
IM - Isola di Man 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PY - Paraguay 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
Totale 24.535
Città #
Singapore 1.691
San Jose 1.279
Chandler 1.132
Jacksonville 1.115
Dublin 824
Ashburn 567
Southend 531
Dallas 440
Council Bluffs 438
Beijing 403
Princeton 392
Izmir 373
Nanjing 322
Dearborn 227
Wilmington 224
Los Angeles 221
Santa Clara 217
Cambridge 187
Ho Chi Minh City 176
Ann Arbor 168
The Dalles 155
Altamura 151
Buffalo 145
Tongling 130
New York 129
Boardman 124
Nanchang 112
Hanoi 108
Munich 106
Woodbridge 98
North Bergen 77
Houston 74
Grevenbroich 73
Shenyang 73
Hong Kong 71
Moscow 71
Chieti 70
São Paulo 64
Pesaro 62
Phoenix 61
Hebei 59
Kimball 53
Tianjin 53
Columbus 52
Chicago 50
Washington 48
Jiaxing 46
Denver 42
Jinan 42
Kunming 40
Montreal 40
Milan 39
Brooklyn 37
Montréal 37
Orem 36
Chennai 35
Atlanta 34
Seoul 33
Tokyo 33
Redondo Beach 32
Warsaw 31
Augusta 30
Pescara 29
Philadelphia 29
Da Nang 28
Hangzhou 28
Rome 28
Toronto 28
Brussels 27
Johannesburg 27
Brno 26
Helsinki 26
Norwalk 26
Boston 25
Orange 25
San Mateo 25
Turku 24
Mcallen 23
Silver Spring 23
Mexico City 22
Ningbo 22
Zhengzhou 22
Hefei 21
London 21
Haiphong 20
St Louis 20
Changsha 19
Seattle 19
Auburn Hills 17
Frankfurt am Main 17
Manchester 17
Poplar 17
Stockholm 17
Dong Ket 16
San Francisco 16
Belo Horizonte 15
Kingston 15
Las Vegas 15
Naples 15
San José 15
Totale 14.608
Nome #
Mast cell recruitment after subcutaneous injection of RANTES in the sole of the rat paw. 266
5-HT and histamine release from rat basophilic leukemia cells treated or non with IL-1RA 202
Inhibitory effect of quercetin on tryptase and MCP-1 chemokine release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line 200
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 199
Analytical Management of Patients Undergoing Oral Anticoagulant Therapy Could Have a Strong Impact on Clinical Outcomes: A Follow-up Study 199
Vascular endothelial growth factor (VEGF), mast cells and inflammation 199
Anti-chemochine therapy for inflammatory diseases 195
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 195
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. 192
Interleukin-6 and mast cells 191
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 188
Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1β levels and expression in peripheral blood mononuclear cells 188
Oxygen supply modulates MCP-1 release in monocytes from young and aged rats: decrease of MCP-1 transcription and translation is age-related 183
Allergen immunotherapy: an effective immune-modifier. 182
Caffeine, Theophylline and bamifylline are similar as competitive inhibitors of 3' ,5'-cyclic AMP phosphodiesterase in vitro 180
A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application 180
Augmentation of monocyte chemotactic protein-1 (MCP-1) and mRNA Transcript in chronic inflammatory states induced by potassium permanganate (KMnO4) in vivo 178
Heme Oxigenase-1 (HO-1) and oxidative stress in rat heart 176
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 174
A scavenger role for nitric oxide in the aged rat kidney. 172
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 172
Bamifylline similar to theophylline and caffeine is a competitive inhibitor of the cyclic nucleotide phosphodiesterase V 170
Microarray expression profiling of human dental pulp from single subject. 170
Nutrition and cancer prevention. 170
Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines 169
Activation and inhibition of adaptive immune response mediated by mast cells 168
Interferon β1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis 168
Different effects of platinum, palladium, and rhodium salts on lymphocyte proliferation and cytokine release 162
Human gingival mesenchymal stem cells pretreated with vesicular moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury 162
Differential TBXA2 receptor transcript stability is dependent on the C924T polymorphism 159
Increase in CD45RO+ cells and activated eosinophils in chronic allergic conjunctivitis. 158
Synergistic activation of serum amyloid a (saa) by il - 6 and il - 1 in combination on human hep 3 b hepatoma cell line. Role of pge2 and il-1 receptor antagonist 157
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 157
A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy. 157
ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY 157
ENOX2 (or tNOX): a new and old molecule with cancer activity involved in tumor prevention and therapy 157
In vitro effects of vanadate on human immune functions 157
Effect of electromagnetic fields on several CD markers and transcription and expression of CD4 156
Endocrinology of the skin: intradermal neuroimmune network, a new frontier 155
Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37 154
The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine 153
Comparison of Serum Total Valproic Acid Levels and %CDT Values in Chronic Alcohol Addictive Patients in an Italian Clinic: A Retrospective Study 153
A new diagnostic approach to better identify antiphospholipid syndrome. 151
Impact of RANTES, MCP-1 and IL-8 in mast cells 149
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 149
Calcium ionophore A23187 and compound 48/80 induce PGD2 and tryptase in human cord blood-derived mast cells: lack of effect of il-18 148
IL-10, an inflammatory/inhibitory cytokine, but not always. 147
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 147
Neuropeptide substance P induces mRNA expression and secretion of CXCL8 chemokine, and HDC in human umbilical cord blood mast cells. 145
Interleukin-9 and mast cells 145
Chemokines as markers for parasite-induced inflammation and tumors 144
Massive infiltration of basophilic cells in inflamed tissue after injection of RANTES. 144
IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation 144
L-carnitine enhances adenosine triphosphate (ATP) and inhibits lymphocite proliferation 144
Relevance of plant lectins in human cell biology and immunology 144
Effect of the compound L-mimosine in an in vivo model of chronic granuloma formation induced by potassium permanganate (KMNO4). 143
The down-regulation of il-6-stimulated fibrinogen steadu state mrna and protein levels by human recombinant il-1 is not pge2-dependent:effects of il-1 receptor antagonist (il-1ra) 142
Monocyte chemotactic protein 1 (MCP-1) activates mast cells to aggregate and release [3H]-5HT 142
Interleukin-17 and the interleukin-17 family member network. 142
IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines 142
Aluminum impairs rat neural cell mitochondria in vitro 141
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 141
Morphostructural analysis of human follicular stem cells on highly porous bone hydroxyapatite scaffold. 141
Effect of interleukin-1 receptor antagonist (IL-1RA) on histamine and serotonin release by rat basophilic leukemia cells (RBL-2H3) and peritoneal mast cells 140
Eosinophil recruiting chemokines are down-regulated in peripheral blood mononuclear cells of allergic patients treated with deflazacort or desloratadine. 140
Detection of nuclear and membrane antigens by liquid-based cytology following long-term storage of d1 cells, karpas cells, and peripheral blood mononuclear cells. 140
Production of cytokines in trichinellosis infected mice 139
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 139
Endothelial Nitric Oxide Synthase (e-NOS)expression and localization in healthy and diabetic rat hearts 139
Infections and mast cells 139
Impact of IL-32 on histamine release by human derived umbilical cord blood mast cells 139
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 138
Tridimensional response of human dental follicular stem cells onto a synthetic hydroxyapatite scaffold. 138
IL-32: a newly-discovered proinflammatory cytokine 138
Monocyte Chemotactis Protein-1 Gene Expression and Translation in Formed Granulomatous Calcified Tissue in Vivo 138
IL-36 a new member of the IL-1 family cytokines 136
Cytokines and allergic disorders: a revisited study 135
Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. 135
Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. 135
Effect of chronic hypoxia on inducible nitric oxide synthase expression in rat myocardial tissue 135
Down regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. 134
Modulation of MCP-1 and iNOS by 50 Hz sinusoidal electromagnetic field 134
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 134
Human recombinant interleukin-1 receptor antagonist (hrIL-1RA) inhibits prostaglandin E2(PGE) generation but not alkaline phosphatase activity in in vivo chronic granulomatous tissue induced by KMnO4 133
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b 133
Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee 133
Advances in therapy with antileukotriene drugs. 133
Interleukin-17: a revisited study. 133
Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increase 3H-thymidine incorporation and the release of 3H arachidonic acid in human macrophages 132
Substance P upregulates LTB4 in rat adherent macrophages from granuloma induced by KMnO4 131
Monocyte chemoattractant protein-1 as a mitogen for vascular smooth muscle cell 129
Will MCP-1 and RANTES take center stage in inflammatory diseases including asthma? 129
Chemokine secretion by mononuclear cells of patients with multiple sclerosis (MS) 129
Induction of monocyte chemotactic protein-1 (MCP-1) and TNF alpha by Trichinella spiralis in serum of mice in vivo 129
Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. 127
Cysteinyl-leukotriene D4 induced IL-1 beta expression ans release in rat vascular smooth muscle cells. 127
rantes and mcp 1 chemokines in nasal mucosa from allergic and non allergic patients preliminary data 126
Rantes and MCP-1 Secretion by Mononuclear Cells of Patients with Nultiple Sclerosis 126
IL-1beta induces alkaline phosphatase in human phagocytes 126
Effect of interleukin-1 receptor antagonist (IL-1RA) on vascular smooth muscle cell proliferation (VSMC). 125
Totale 15.361
Categoria #
all - tutte 96.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.779


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022578 0 0 0 0 64 3 16 64 54 26 104 247
2022/20232.982 258 380 181 360 328 587 162 194 373 34 62 63
2023/20241.135 95 40 66 38 63 314 313 37 19 21 13 116
2024/20253.225 234 596 579 59 69 89 47 148 281 139 364 620
2025/20266.440 539 312 752 736 568 469 1.052 445 638 501 352 76
2026/20272.663 116 557 448 1.039 503 0 0 0 0 0 0 0
Totale 25.087